Beta-blockers or Placebo for Primary Prophylaxis (BOPPP) of oesophageal varices: study protocol for a randomised controlled trial Article Swipe
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1186/s13063-024-08063-3
Background Liver disease is within the top five causes of premature death in adults. Deaths caused by complications of cirrhosis continue to rise, whilst deaths related to other non-liver disease areas are declining. Portal hypertension is the primary sequelae of cirrhosis and is associated with the development of variceal haemorrhage, ascites, hepatic encephalopathy and infection, collectively termed hepatic decompensation, which leads to hospitalisation and mortality. It remains uncertain whether administering a non-selective beta-blocker (NSBB), specifically carvedilol, at an earlier stage, i.e. when oesophageal varices are small, can prevent VH and reduce all-cause decompensation (ACD). Methods/design The BOPPP trial is a pragmatic, multicentre, placebo-controlled, triple-blinded, randomised controlled trial (RCT) in England, Scotland, Wales and Northern Ireland. Patients aged 18 years or older with cirrhosis and small oesophageal varices that have never bled will be recruited, subject to exclusion criteria. The trial aims to enrol 740 patients across 55 hospitals in the UK. Patients are allocated randomly on a 1:1 ratio to receive either carvedilol 6.25 mg (a NSBB) or a matched placebo, once or twice daily, for 36 months, to attain adequate power to determine the effectiveness of carvedilol in preventing or reducing ACD. The primary outcome is the time to first decompensating event. It is a composite primary outcome made up of variceal haemorrhage (VH, new or worsening ascites, new or worsening hepatic encephalopathy (HE), spontaneous bacterial peritonitis (SBP), hepatorenal syndrome, an increase in Child–Pugh grade by 1 grade or MELD score by 5 points, and liver-related mortality. Secondary outcomes include progression to medium or large oesophageal varices, development of gastric, duodenal, or ectopic varices, participant quality of life, healthcare costs and transplant-free survival. Discussion The BOPPP trial aims to investigate the clinical and cost-effectiveness of carvedilol in patients with cirrhosis and small oesophageal varices to determine whether this non-selective beta-blocker can prevent or reduce hepatic decompensation. There is clinical equipoise on whether intervening in cirrhosis, at an earlier stage of portal hypertension, with NSBB therapy is beneficial. Should the trial yield a positive result, we anticipate that the administration and use of carvedilol will become widespread with pathways developed to standardise the administration of the medication in primary care. Ethics and dissemination The trial has been approved by the National Health Service (NHS) Research Ethics Committee (REC) (reference number: 19/YH/0015). The results of the trial will be submitted for publication in a peer-reviewed scientific journal. Participants will be informed of the results via the BOPPP website ( www.boppp-trial.org ) and partners in the British Liver Trust (BLT) organisation. Trial registration EUDRACT reference number: 2018–002509-78. ISRCTN reference number: ISRCTN10324656. Registered on April 24 2019.
Related Topics
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1186/s13063-024-08063-3
- https://trialsjournal.biomedcentral.com/counter/pdf/10.1186/s13063-024-08063-3
- OA Status
- gold
- Cited By
- 5
- References
- 22
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4394844831
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4394844831Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1186/s13063-024-08063-3Digital Object Identifier
- Title
-
Beta-blockers or Placebo for Primary Prophylaxis (BOPPP) of oesophageal varices: study protocol for a randomised controlled trialWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-04-16Full publication date if available
- Authors
-
Vishal Patel, Mark McPhail, Ruhama Uddin, Hassan Jafari, Vanessa Lawrence, Clair Le Boutillier, James Shearer, Nahel Yaziji, Angela Cape, Haroon Ahmed, Christopher D. Ward, Peter Walsh, Kevin Besly, Ane Zamalloa, Joanna Kelly, Ashis Mukhopadhya, Alicija Vileito, Tracy Henderson, Gwilym J. Webb, Jerrian Joyce Andrada, Abigail Ford, Cyril Sieberhagen, Claire Burston, Carol Brooks, Gavin Wright, Bushena Miyesa, Aimee Williams, Jay Patel, Melchizedek Penacerrada, Gautham Appanna, Gifthy Perez, Joanne Elliott, Keval Naik, Susan Smolen, Anna Beckwith, Matthew Foxton, Carina Bautista, Matthew Cramp, Ada Laureen Nweze, Gayatri Chakrabarty, Indhuja Rajkumar, Merlin James, Steven Masson, Sheenu Thomas, Lucy Dixon, S. Hogg, Louise Finlay, Kuldeep Cheent, Jessica K. Camp, Adrian J. Stanley, Alexis Duncan, Lauren Walker, Duncan Napier, Paula Hilltout, Linda Hill, Hiromi Uzu, Moby Joseph, Suzannah Pegler, Camille Walling, Lynsey Corless, Anisoara Kingsbury, Tania Nurun, Debasish Das, Anna Williams, Stephen Foley, C W Goodwin, Markus Gess, Margaret Grout, Ka‐Kit Li, Olivia Watchorn, Laura S. Plummer, Laura Blackmore, Christos Tsintikidis, Alexia A. Perryman, G. W. G. Bird, Emily Phiri, Mohamed Saleh, A.O. Woghiren, Dilukshi Wickramasinghe, Jodie Wright, Michael H. Miller, Shona Murray, Leanne Cosgrove, John Hutchinson, Julie Burton, E Stoner, Stephanie Lupton, Mayur Kumar, Nicola Griffiths, Anna Posada, Andrew Fowell, Avisnata Das, Jincy Daniel, Anu Rose Andrews, Dhiraj Tripathi, Emma Burke, E. R. EAVES, H Emms, Dina Mansour, Ann WilsonList of authors in order
- Landing page
-
https://doi.org/10.1186/s13063-024-08063-3Publisher landing page
- PDF URL
-
https://trialsjournal.biomedcentral.com/counter/pdf/10.1186/s13063-024-08063-3Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://trialsjournal.biomedcentral.com/counter/pdf/10.1186/s13063-024-08063-3Direct OA link when available
- Concepts
-
Medicine, Spontaneous bacterial peritonitis, Carvedilol, Varices, Cirrhosis, Hepatic encephalopathy, Hepatorenal syndrome, Randomized controlled trial, Ascites, Portal hypertension, Clinical endpoint, Placebo, Internal medicine, Decompensation, Esophageal varices, Liver disease, Gastroenterology, Surgery, Heart failure, Pathology, Alternative medicineTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
5Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 3, 2024: 2Per-year citation counts (last 5 years)
- References (count)
-
22Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4394844831 |
|---|---|
| doi | https://doi.org/10.1186/s13063-024-08063-3 |
| ids.doi | https://doi.org/10.1186/s13063-024-08063-3 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/38627804 |
| ids.openalex | https://openalex.org/W4394844831 |
| fwci | 4.19517667 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D000328 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Adult |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D006801 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | Humans |
| mesh[2].qualifier_ui | Q000175 |
| mesh[2].descriptor_ui | D004932 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | diagnosis |
| mesh[2].descriptor_name | Esophageal and Gastric Varices |
| mesh[3].qualifier_ui | Q000209 |
| mesh[3].descriptor_ui | D004932 |
| mesh[3].is_major_topic | True |
| mesh[3].qualifier_name | etiology |
| mesh[3].descriptor_name | Esophageal and Gastric Varices |
| mesh[4].qualifier_ui | Q000517 |
| mesh[4].descriptor_ui | D004932 |
| mesh[4].is_major_topic | True |
| mesh[4].qualifier_name | prevention & control |
| mesh[4].descriptor_name | Esophageal and Gastric Varices |
| mesh[5].qualifier_ui | Q000009 |
| mesh[5].descriptor_ui | D000077261 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | adverse effects |
| mesh[5].descriptor_name | Carvedilol |
| mesh[6].qualifier_ui | Q000175 |
| mesh[6].descriptor_ui | D006501 |
| mesh[6].is_major_topic | True |
| mesh[6].qualifier_name | diagnosis |
| mesh[6].descriptor_name | Hepatic Encephalopathy |
| mesh[7].qualifier_ui | Q000188 |
| mesh[7].descriptor_ui | D006501 |
| mesh[7].is_major_topic | True |
| mesh[7].qualifier_name | drug therapy |
| mesh[7].descriptor_name | Hepatic Encephalopathy |
| mesh[8].qualifier_ui | Q000209 |
| mesh[8].descriptor_ui | D006501 |
| mesh[8].is_major_topic | True |
| mesh[8].qualifier_name | etiology |
| mesh[8].descriptor_name | Hepatic Encephalopathy |
| mesh[9].qualifier_ui | Q000188 |
| mesh[9].descriptor_ui | D001201 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | drug therapy |
| mesh[9].descriptor_name | Ascites |
| mesh[10].qualifier_ui | Q000175 |
| mesh[10].descriptor_ui | D006471 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | diagnosis |
| mesh[10].descriptor_name | Gastrointestinal Hemorrhage |
| mesh[11].qualifier_ui | Q000209 |
| mesh[11].descriptor_ui | D006471 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | etiology |
| mesh[11].descriptor_name | Gastrointestinal Hemorrhage |
| mesh[12].qualifier_ui | Q000517 |
| mesh[12].descriptor_ui | D006471 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | prevention & control |
| mesh[12].descriptor_name | Gastrointestinal Hemorrhage |
| mesh[13].qualifier_ui | Q000009 |
| mesh[13].descriptor_ui | D000319 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | adverse effects |
| mesh[13].descriptor_name | Adrenergic beta-Antagonists |
| mesh[14].qualifier_ui | Q000150 |
| mesh[14].descriptor_ui | D006975 |
| mesh[14].is_major_topic | True |
| mesh[14].qualifier_name | complications |
| mesh[14].descriptor_name | Hypertension, Portal |
| mesh[15].qualifier_ui | Q000175 |
| mesh[15].descriptor_ui | D006975 |
| mesh[15].is_major_topic | True |
| mesh[15].qualifier_name | diagnosis |
| mesh[15].descriptor_name | Hypertension, Portal |
| mesh[16].qualifier_ui | Q000188 |
| mesh[16].descriptor_ui | D006975 |
| mesh[16].is_major_topic | True |
| mesh[16].qualifier_name | drug therapy |
| mesh[16].descriptor_name | Hypertension, Portal |
| mesh[17].qualifier_ui | Q000150 |
| mesh[17].descriptor_ui | D008103 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | complications |
| mesh[17].descriptor_name | Liver Cirrhosis |
| mesh[18].qualifier_ui | Q000175 |
| mesh[18].descriptor_ui | D008103 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | diagnosis |
| mesh[18].descriptor_name | Liver Cirrhosis |
| mesh[19].qualifier_ui | Q000188 |
| mesh[19].descriptor_ui | D008103 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | drug therapy |
| mesh[19].descriptor_name | Liver Cirrhosis |
| mesh[20].qualifier_ui | |
| mesh[20].descriptor_ui | D016032 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | |
| mesh[20].descriptor_name | Randomized Controlled Trials as Topic |
| mesh[21].qualifier_ui | |
| mesh[21].descriptor_ui | D015337 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | |
| mesh[21].descriptor_name | Multicenter Studies as Topic |
| mesh[22].qualifier_ui | |
| mesh[22].descriptor_ui | D000328 |
| mesh[22].is_major_topic | False |
| mesh[22].qualifier_name | |
| mesh[22].descriptor_name | Adult |
| mesh[23].qualifier_ui | |
| mesh[23].descriptor_ui | D006801 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | |
| mesh[23].descriptor_name | Humans |
| mesh[24].qualifier_ui | Q000627 |
| mesh[24].descriptor_ui | D000319 |
| mesh[24].is_major_topic | False |
| mesh[24].qualifier_name | therapeutic use |
| mesh[24].descriptor_name | Adrenergic beta-Antagonists |
| mesh[25].qualifier_ui | Q000188 |
| mesh[25].descriptor_ui | D001201 |
| mesh[25].is_major_topic | False |
| mesh[25].qualifier_name | drug therapy |
| mesh[25].descriptor_name | Ascites |
| mesh[26].qualifier_ui | Q000627 |
| mesh[26].descriptor_ui | D000077261 |
| mesh[26].is_major_topic | False |
| mesh[26].qualifier_name | therapeutic use |
| mesh[26].descriptor_name | Carvedilol |
| mesh[27].qualifier_ui | Q000175 |
| mesh[27].descriptor_ui | D004932 |
| mesh[27].is_major_topic | True |
| mesh[27].qualifier_name | diagnosis |
| mesh[27].descriptor_name | Esophageal and Gastric Varices |
| mesh[28].qualifier_ui | Q000209 |
| mesh[28].descriptor_ui | D004932 |
| mesh[28].is_major_topic | True |
| mesh[28].qualifier_name | etiology |
| mesh[28].descriptor_name | Esophageal and Gastric Varices |
| mesh[29].qualifier_ui | Q000517 |
| mesh[29].descriptor_ui | D004932 |
| mesh[29].is_major_topic | True |
| mesh[29].qualifier_name | prevention & control |
| mesh[29].descriptor_name | Esophageal and Gastric Varices |
| mesh[30].qualifier_ui | Q000175 |
| mesh[30].descriptor_ui | D006471 |
| mesh[30].is_major_topic | False |
| mesh[30].qualifier_name | diagnosis |
| mesh[30].descriptor_name | Gastrointestinal Hemorrhage |
| mesh[31].qualifier_ui | Q000209 |
| mesh[31].descriptor_ui | D006471 |
| mesh[31].is_major_topic | False |
| mesh[31].qualifier_name | etiology |
| mesh[31].descriptor_name | Gastrointestinal Hemorrhage |
| mesh[32].qualifier_ui | Q000517 |
| mesh[32].descriptor_ui | D006471 |
| mesh[32].is_major_topic | False |
| mesh[32].qualifier_name | prevention & control |
| mesh[32].descriptor_name | Gastrointestinal Hemorrhage |
| mesh[33].qualifier_ui | Q000175 |
| mesh[33].descriptor_ui | D006501 |
| mesh[33].is_major_topic | True |
| mesh[33].qualifier_name | diagnosis |
| mesh[33].descriptor_name | Hepatic Encephalopathy |
| mesh[34].qualifier_ui | Q000188 |
| mesh[34].descriptor_ui | D006501 |
| mesh[34].is_major_topic | True |
| mesh[34].qualifier_name | drug therapy |
| mesh[34].descriptor_name | Hepatic Encephalopathy |
| mesh[35].qualifier_ui | Q000209 |
| mesh[35].descriptor_ui | D006501 |
| mesh[35].is_major_topic | True |
| mesh[35].qualifier_name | etiology |
| mesh[35].descriptor_name | Hepatic Encephalopathy |
| mesh[36].qualifier_ui | Q000150 |
| mesh[36].descriptor_ui | D006975 |
| mesh[36].is_major_topic | True |
| mesh[36].qualifier_name | complications |
| mesh[36].descriptor_name | Hypertension, Portal |
| mesh[37].qualifier_ui | Q000175 |
| mesh[37].descriptor_ui | D006975 |
| mesh[37].is_major_topic | True |
| mesh[37].qualifier_name | diagnosis |
| mesh[37].descriptor_name | Hypertension, Portal |
| mesh[38].qualifier_ui | Q000188 |
| mesh[38].descriptor_ui | D006975 |
| mesh[38].is_major_topic | True |
| mesh[38].qualifier_name | drug therapy |
| mesh[38].descriptor_name | Hypertension, Portal |
| mesh[39].qualifier_ui | Q000150 |
| mesh[39].descriptor_ui | D008103 |
| mesh[39].is_major_topic | False |
| mesh[39].qualifier_name | complications |
| mesh[39].descriptor_name | Liver Cirrhosis |
| mesh[40].qualifier_ui | Q000175 |
| mesh[40].descriptor_ui | D008103 |
| mesh[40].is_major_topic | False |
| mesh[40].qualifier_name | diagnosis |
| mesh[40].descriptor_name | Liver Cirrhosis |
| mesh[41].qualifier_ui | Q000188 |
| mesh[41].descriptor_ui | D008103 |
| mesh[41].is_major_topic | False |
| mesh[41].qualifier_name | drug therapy |
| mesh[41].descriptor_name | Liver Cirrhosis |
| mesh[42].qualifier_ui | |
| mesh[42].descriptor_ui | D015337 |
| mesh[42].is_major_topic | False |
| mesh[42].qualifier_name | |
| mesh[42].descriptor_name | Multicenter Studies as Topic |
| mesh[43].qualifier_ui | |
| mesh[43].descriptor_ui | D016032 |
| mesh[43].is_major_topic | False |
| mesh[43].qualifier_name | |
| mesh[43].descriptor_name | Randomized Controlled Trials as Topic |
| mesh[44].qualifier_ui | |
| mesh[44].descriptor_ui | D064792 |
| mesh[44].is_major_topic | False |
| mesh[44].qualifier_name | |
| mesh[44].descriptor_name | Pragmatic Clinical Trials as Topic |
| mesh[45].qualifier_ui | |
| mesh[45].descriptor_ui | D000328 |
| mesh[45].is_major_topic | False |
| mesh[45].qualifier_name | |
| mesh[45].descriptor_name | Adult |
| mesh[46].qualifier_ui | |
| mesh[46].descriptor_ui | D006801 |
| mesh[46].is_major_topic | False |
| mesh[46].qualifier_name | |
| mesh[46].descriptor_name | Humans |
| mesh[47].qualifier_ui | Q000627 |
| mesh[47].descriptor_ui | D000319 |
| mesh[47].is_major_topic | False |
| mesh[47].qualifier_name | therapeutic use |
| mesh[47].descriptor_name | Adrenergic beta-Antagonists |
| mesh[48].qualifier_ui | Q000188 |
| mesh[48].descriptor_ui | D001201 |
| mesh[48].is_major_topic | False |
| mesh[48].qualifier_name | drug therapy |
| mesh[48].descriptor_name | Ascites |
| mesh[49].qualifier_ui | Q000627 |
| mesh[49].descriptor_ui | D000077261 |
| mesh[49].is_major_topic | False |
| mesh[49].qualifier_name | therapeutic use |
| mesh[49].descriptor_name | Carvedilol |
| type | article |
| title | Beta-blockers or Placebo for Primary Prophylaxis (BOPPP) of oesophageal varices: study protocol for a randomised controlled trial |
| awards[0].id | https://openalex.org/G7679316000 |
| awards[0].funder_id | https://openalex.org/F4320334661 |
| awards[0].display_name | |
| awards[0].funder_award_id | 17/32/04 |
| awards[0].funder_display_name | Health Technology Assessment Programme |
| biblio.issue | 1 |
| biblio.volume | 25 |
| biblio.last_page | 265 |
| biblio.first_page | 265 |
| topics[0].id | https://openalex.org/T10337 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 1.0 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2721 |
| topics[0].subfield.display_name | Hepatology |
| topics[0].display_name | Liver Disease and Transplantation |
| topics[1].id | https://openalex.org/T10351 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9977999925613403 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2713 |
| topics[1].subfield.display_name | Epidemiology |
| topics[1].display_name | Liver Disease Diagnosis and Treatment |
| topics[2].id | https://openalex.org/T10999 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9937999844551086 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2746 |
| topics[2].subfield.display_name | Surgery |
| topics[2].display_name | Organ Transplantation Techniques and Outcomes |
| funders[0].id | https://openalex.org/F4320334661 |
| funders[0].ror | https://ror.org/0187kwz08 |
| funders[0].display_name | Health Technology Assessment Programme |
| is_xpac | False |
| apc_list.value | 1570 |
| apc_list.currency | GBP |
| apc_list.value_usd | 1925 |
| apc_paid.value | 1570 |
| apc_paid.currency | GBP |
| apc_paid.value_usd | 1925 |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.9394478797912598 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C2777364826 |
| concepts[1].level | 3 |
| concepts[1].score | 0.7541114091873169 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q3128789 |
| concepts[1].display_name | Spontaneous bacterial peritonitis |
| concepts[2].id | https://openalex.org/C2780591200 |
| concepts[2].level | 3 |
| concepts[2].score | 0.7507676482200623 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q412534 |
| concepts[2].display_name | Carvedilol |
| concepts[3].id | https://openalex.org/C2778012290 |
| concepts[3].level | 3 |
| concepts[3].score | 0.6396463513374329 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q2624485 |
| concepts[3].display_name | Varices |
| concepts[4].id | https://openalex.org/C2777214474 |
| concepts[4].level | 2 |
| concepts[4].score | 0.6301093697547913 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q147778 |
| concepts[4].display_name | Cirrhosis |
| concepts[5].id | https://openalex.org/C2780325230 |
| concepts[5].level | 3 |
| concepts[5].score | 0.5961211323738098 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q642548 |
| concepts[5].display_name | Hepatic encephalopathy |
| concepts[6].id | https://openalex.org/C2776988256 |
| concepts[6].level | 3 |
| concepts[6].score | 0.595099687576294 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q247131 |
| concepts[6].display_name | Hepatorenal syndrome |
| concepts[7].id | https://openalex.org/C168563851 |
| concepts[7].level | 2 |
| concepts[7].score | 0.575008749961853 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q1436668 |
| concepts[7].display_name | Randomized controlled trial |
| concepts[8].id | https://openalex.org/C2780496750 |
| concepts[8].level | 2 |
| concepts[8].score | 0.568805992603302 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q193889 |
| concepts[8].display_name | Ascites |
| concepts[9].id | https://openalex.org/C2778808290 |
| concepts[9].level | 3 |
| concepts[9].score | 0.5482563972473145 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q124604 |
| concepts[9].display_name | Portal hypertension |
| concepts[10].id | https://openalex.org/C203092338 |
| concepts[10].level | 3 |
| concepts[10].score | 0.5433155298233032 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q1340863 |
| concepts[10].display_name | Clinical endpoint |
| concepts[11].id | https://openalex.org/C27081682 |
| concepts[11].level | 3 |
| concepts[11].score | 0.5420447587966919 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q269829 |
| concepts[11].display_name | Placebo |
| concepts[12].id | https://openalex.org/C126322002 |
| concepts[12].level | 1 |
| concepts[12].score | 0.5251326560974121 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[12].display_name | Internal medicine |
| concepts[13].id | https://openalex.org/C2778721985 |
| concepts[13].level | 2 |
| concepts[13].score | 0.4852485656738281 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q1183680 |
| concepts[13].display_name | Decompensation |
| concepts[14].id | https://openalex.org/C2777595160 |
| concepts[14].level | 4 |
| concepts[14].score | 0.46491342782974243 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q298278 |
| concepts[14].display_name | Esophageal varices |
| concepts[15].id | https://openalex.org/C2777075537 |
| concepts[15].level | 2 |
| concepts[15].score | 0.452381432056427 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q929737 |
| concepts[15].display_name | Liver disease |
| concepts[16].id | https://openalex.org/C90924648 |
| concepts[16].level | 1 |
| concepts[16].score | 0.3620506227016449 |
| concepts[16].wikidata | https://www.wikidata.org/wiki/Q120569 |
| concepts[16].display_name | Gastroenterology |
| concepts[17].id | https://openalex.org/C141071460 |
| concepts[17].level | 1 |
| concepts[17].score | 0.34091535210609436 |
| concepts[17].wikidata | https://www.wikidata.org/wiki/Q40821 |
| concepts[17].display_name | Surgery |
| concepts[18].id | https://openalex.org/C2778198053 |
| concepts[18].level | 2 |
| concepts[18].score | 0.18908491730690002 |
| concepts[18].wikidata | https://www.wikidata.org/wiki/Q181754 |
| concepts[18].display_name | Heart failure |
| concepts[19].id | https://openalex.org/C142724271 |
| concepts[19].level | 1 |
| concepts[19].score | 0.0 |
| concepts[19].wikidata | https://www.wikidata.org/wiki/Q7208 |
| concepts[19].display_name | Pathology |
| concepts[20].id | https://openalex.org/C204787440 |
| concepts[20].level | 2 |
| concepts[20].score | 0.0 |
| concepts[20].wikidata | https://www.wikidata.org/wiki/Q188504 |
| concepts[20].display_name | Alternative medicine |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.9394478797912598 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/spontaneous-bacterial-peritonitis |
| keywords[1].score | 0.7541114091873169 |
| keywords[1].display_name | Spontaneous bacterial peritonitis |
| keywords[2].id | https://openalex.org/keywords/carvedilol |
| keywords[2].score | 0.7507676482200623 |
| keywords[2].display_name | Carvedilol |
| keywords[3].id | https://openalex.org/keywords/varices |
| keywords[3].score | 0.6396463513374329 |
| keywords[3].display_name | Varices |
| keywords[4].id | https://openalex.org/keywords/cirrhosis |
| keywords[4].score | 0.6301093697547913 |
| keywords[4].display_name | Cirrhosis |
| keywords[5].id | https://openalex.org/keywords/hepatic-encephalopathy |
| keywords[5].score | 0.5961211323738098 |
| keywords[5].display_name | Hepatic encephalopathy |
| keywords[6].id | https://openalex.org/keywords/hepatorenal-syndrome |
| keywords[6].score | 0.595099687576294 |
| keywords[6].display_name | Hepatorenal syndrome |
| keywords[7].id | https://openalex.org/keywords/randomized-controlled-trial |
| keywords[7].score | 0.575008749961853 |
| keywords[7].display_name | Randomized controlled trial |
| keywords[8].id | https://openalex.org/keywords/ascites |
| keywords[8].score | 0.568805992603302 |
| keywords[8].display_name | Ascites |
| keywords[9].id | https://openalex.org/keywords/portal-hypertension |
| keywords[9].score | 0.5482563972473145 |
| keywords[9].display_name | Portal hypertension |
| keywords[10].id | https://openalex.org/keywords/clinical-endpoint |
| keywords[10].score | 0.5433155298233032 |
| keywords[10].display_name | Clinical endpoint |
| keywords[11].id | https://openalex.org/keywords/placebo |
| keywords[11].score | 0.5420447587966919 |
| keywords[11].display_name | Placebo |
| keywords[12].id | https://openalex.org/keywords/internal-medicine |
| keywords[12].score | 0.5251326560974121 |
| keywords[12].display_name | Internal medicine |
| keywords[13].id | https://openalex.org/keywords/decompensation |
| keywords[13].score | 0.4852485656738281 |
| keywords[13].display_name | Decompensation |
| keywords[14].id | https://openalex.org/keywords/esophageal-varices |
| keywords[14].score | 0.46491342782974243 |
| keywords[14].display_name | Esophageal varices |
| keywords[15].id | https://openalex.org/keywords/liver-disease |
| keywords[15].score | 0.452381432056427 |
| keywords[15].display_name | Liver disease |
| keywords[16].id | https://openalex.org/keywords/gastroenterology |
| keywords[16].score | 0.3620506227016449 |
| keywords[16].display_name | Gastroenterology |
| keywords[17].id | https://openalex.org/keywords/surgery |
| keywords[17].score | 0.34091535210609436 |
| keywords[17].display_name | Surgery |
| keywords[18].id | https://openalex.org/keywords/heart-failure |
| keywords[18].score | 0.18908491730690002 |
| keywords[18].display_name | Heart failure |
| language | en |
| locations[0].id | doi:10.1186/s13063-024-08063-3 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S109512841 |
| locations[0].source.issn | 1745-6215 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 1745-6215 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Trials |
| locations[0].source.host_organization | https://openalex.org/P4310319900 |
| locations[0].source.host_organization_name | Springer Science+Business Media |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310319900, https://openalex.org/P4310319965 |
| locations[0].source.host_organization_lineage_names | Springer Science+Business Media, Springer Nature |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://trialsjournal.biomedcentral.com/counter/pdf/10.1186/s13063-024-08063-3 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Trials |
| locations[0].landing_page_url | https://doi.org/10.1186/s13063-024-08063-3 |
| locations[1].id | pmid:38627804 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Trials |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/38627804 |
| locations[2].id | pmh:oai:doaj.org/article:2811c9fe2103403da5e259a0f10a1481 |
| locations[2].is_oa | False |
| locations[2].source.id | https://openalex.org/S4306401280 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[2].source.host_organization | |
| locations[2].source.host_organization_name | |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | acceptedVersion |
| locations[2].raw_type | article |
| locations[2].license_id | |
| locations[2].is_accepted | True |
| locations[2].is_published | False |
| locations[2].raw_source_name | Trials, Vol 25, Iss 1, Pp 1-16 (2024) |
| locations[2].landing_page_url | https://doaj.org/article/2811c9fe2103403da5e259a0f10a1481 |
| locations[3].id | pmh:oai:https://orca.cardiff.ac.uk:168017 |
| locations[3].is_oa | False |
| locations[3].source.id | https://openalex.org/S4306400871 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | Spectrum Research Repository (Concordia University) |
| locations[3].source.host_organization | https://openalex.org/I60158472 |
| locations[3].source.host_organization_name | Concordia University |
| locations[3].source.host_organization_lineage | https://openalex.org/I60158472 |
| locations[3].license | |
| locations[3].pdf_url | |
| locations[3].version | acceptedVersion |
| locations[3].raw_type | Article |
| locations[3].license_id | |
| locations[3].is_accepted | True |
| locations[3].is_published | False |
| locations[3].raw_source_name | |
| locations[3].landing_page_url | |
| locations[4].id | pmh:oai:kclpure.kcl.ac.uk:publications/83c68b12-6a8f-42dd-a747-337bd07de91f |
| locations[4].is_oa | True |
| locations[4].source | |
| locations[4].license | other-oa |
| locations[4].pdf_url | |
| locations[4].version | acceptedVersion |
| locations[4].raw_type | article |
| locations[4].license_id | https://openalex.org/licenses/other-oa |
| locations[4].is_accepted | True |
| locations[4].is_published | False |
| locations[4].raw_source_name | Patel , V , McPhail , M , Uddin , R , Jafari , H , Lawrence , V , Le Boutillier , C , Shearer , J , Yaziji , N , Cape , A , Ahmed , H , Ward , C , Walsh , P , Besly , K , Zamalloa , A & Kelly , J & Carter , B 2024 , ' Beta-blockers or Placebo for Primary Prophylaxis (BOPPP) of oesophageal varices : study protocol for a randomised controlled trial ' , Trials , vol. 25 , no. 1 , 265 . https://doi.org/10.1186/s13063-024-08063-3 |
| locations[4].landing_page_url | https://kclpure.kcl.ac.uk/portal/en/publications/83c68b12-6a8f-42dd-a747-337bd07de91f |
| locations[5].id | pmh:oai:pubmedcentral.nih.gov:11022376 |
| locations[5].is_oa | True |
| locations[5].source.id | https://openalex.org/S2764455111 |
| locations[5].source.issn | |
| locations[5].source.type | repository |
| locations[5].source.is_oa | False |
| locations[5].source.issn_l | |
| locations[5].source.is_core | False |
| locations[5].source.is_in_doaj | False |
| locations[5].source.display_name | PubMed Central |
| locations[5].source.host_organization | https://openalex.org/I1299303238 |
| locations[5].source.host_organization_name | National Institutes of Health |
| locations[5].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[5].license | other-oa |
| locations[5].pdf_url | |
| locations[5].version | acceptedVersion |
| locations[5].raw_type | Text |
| locations[5].license_id | https://openalex.org/licenses/other-oa |
| locations[5].is_accepted | True |
| locations[5].is_published | False |
| locations[5].raw_source_name | Trials |
| locations[5].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/11022376 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5080274937 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-6616-3628 |
| authorships[0].author.display_name | Vishal Patel |
| authorships[0].countries | GB |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210111135 |
| authorships[0].affiliations[0].raw_affiliation_string | Institute of Liver Studies, King's College Hospital NHS Foundation Trust, London, UK |
| authorships[0].institutions[0].id | https://openalex.org/I4210111135 |
| authorships[0].institutions[0].ror | https://ror.org/01n0k5m85 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210111135 |
| authorships[0].institutions[0].country_code | GB |
| authorships[0].institutions[0].display_name | King's College Hospital NHS Foundation Trust |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Vishal C. Patel |
| authorships[0].is_corresponding | True |
| authorships[0].raw_affiliation_strings | Institute of Liver Studies, King's College Hospital NHS Foundation Trust, London, UK |
| authorships[1].author.id | https://openalex.org/A5072083457 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-5449-2424 |
| authorships[1].author.display_name | Mark McPhail |
| authorships[1].countries | GB |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210111135 |
| authorships[1].affiliations[0].raw_affiliation_string | Institute of Liver Studies, King's College Hospital NHS Foundation Trust, London, UK |
| authorships[1].institutions[0].id | https://openalex.org/I4210111135 |
| authorships[1].institutions[0].ror | https://ror.org/01n0k5m85 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210111135 |
| authorships[1].institutions[0].country_code | GB |
| authorships[1].institutions[0].display_name | King's College Hospital NHS Foundation Trust |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Mark J. McPhail |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Institute of Liver Studies, King's College Hospital NHS Foundation Trust, London, UK |
| authorships[2].author.id | https://openalex.org/A5015732932 |
| authorships[2].author.orcid | https://orcid.org/0009-0000-6383-6735 |
| authorships[2].author.display_name | Ruhama Uddin |
| authorships[2].countries | GB |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210111135 |
| authorships[2].affiliations[0].raw_affiliation_string | Institute of Liver Studies, King's College Hospital NHS Foundation Trust, London, UK |
| authorships[2].institutions[0].id | https://openalex.org/I4210111135 |
| authorships[2].institutions[0].ror | https://ror.org/01n0k5m85 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210111135 |
| authorships[2].institutions[0].country_code | GB |
| authorships[2].institutions[0].display_name | King's College Hospital NHS Foundation Trust |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Ruhama Uddin |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Institute of Liver Studies, King's College Hospital NHS Foundation Trust, London, UK |
| authorships[3].author.id | https://openalex.org/A5103008102 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-4541-6419 |
| authorships[3].author.display_name | Hassan Jafari |
| authorships[3].countries | GB |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I183935753 |
| authorships[3].affiliations[0].raw_affiliation_string | Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK |
| authorships[3].institutions[0].id | https://openalex.org/I183935753 |
| authorships[3].institutions[0].ror | https://ror.org/0220mzb33 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I124357947, https://openalex.org/I183935753 |
| authorships[3].institutions[0].country_code | GB |
| authorships[3].institutions[0].display_name | King's College London |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Hassan Jafari |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK |
| authorships[4].author.id | https://openalex.org/A5090108216 |
| authorships[4].author.orcid | https://orcid.org/0000-0001-7852-2018 |
| authorships[4].author.display_name | Vanessa Lawrence |
| authorships[4].countries | GB |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I183935753 |
| authorships[4].affiliations[0].raw_affiliation_string | Health Service and Population Research Department, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK |
| authorships[4].institutions[0].id | https://openalex.org/I183935753 |
| authorships[4].institutions[0].ror | https://ror.org/0220mzb33 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I124357947, https://openalex.org/I183935753 |
| authorships[4].institutions[0].country_code | GB |
| authorships[4].institutions[0].display_name | King's College London |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Vanessa Lawrence |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Health Service and Population Research Department, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK |
| authorships[5].author.id | https://openalex.org/A5018097626 |
| authorships[5].author.orcid | https://orcid.org/0000-0003-3665-0315 |
| authorships[5].author.display_name | Clair Le Boutillier |
| authorships[5].countries | GB |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I183935753 |
| authorships[5].affiliations[0].raw_affiliation_string | Health Service and Population Research Department, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK |
| authorships[5].institutions[0].id | https://openalex.org/I183935753 |
| authorships[5].institutions[0].ror | https://ror.org/0220mzb33 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I124357947, https://openalex.org/I183935753 |
| authorships[5].institutions[0].country_code | GB |
| authorships[5].institutions[0].display_name | King's College London |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Clair Le Boutillier |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Health Service and Population Research Department, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK |
| authorships[6].author.id | https://openalex.org/A5085218809 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-1658-9767 |
| authorships[6].author.display_name | James Shearer |
| authorships[6].countries | GB |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I183935753 |
| authorships[6].affiliations[0].raw_affiliation_string | Health Service and Population Research Department, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK |
| authorships[6].institutions[0].id | https://openalex.org/I183935753 |
| authorships[6].institutions[0].ror | https://ror.org/0220mzb33 |
| authorships[6].institutions[0].type | education |
| authorships[6].institutions[0].lineage | https://openalex.org/I124357947, https://openalex.org/I183935753 |
| authorships[6].institutions[0].country_code | GB |
| authorships[6].institutions[0].display_name | King's College London |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | James Shearer |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Health Service and Population Research Department, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK |
| authorships[7].author.id | https://openalex.org/A5028645086 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-2273-7957 |
| authorships[7].author.display_name | Nahel Yaziji |
| authorships[7].countries | GB |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I183935753 |
| authorships[7].affiliations[0].raw_affiliation_string | Health Service and Population Research Department, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK |
| authorships[7].institutions[0].id | https://openalex.org/I183935753 |
| authorships[7].institutions[0].ror | https://ror.org/0220mzb33 |
| authorships[7].institutions[0].type | education |
| authorships[7].institutions[0].lineage | https://openalex.org/I124357947, https://openalex.org/I183935753 |
| authorships[7].institutions[0].country_code | GB |
| authorships[7].institutions[0].display_name | King's College London |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Nahel Yaziji |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Health Service and Population Research Department, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK |
| authorships[8].author.id | https://openalex.org/A5040353449 |
| authorships[8].author.orcid | https://orcid.org/0000-0003-4893-1325 |
| authorships[8].author.display_name | Angela Cape |
| authorships[8].countries | GB |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I183935753 |
| authorships[8].affiliations[0].raw_affiliation_string | King's Clinical Trials Unit, Institute of Psychiatry, Psychology & Neuroscience,, King's College London, London, UK |
| authorships[8].institutions[0].id | https://openalex.org/I183935753 |
| authorships[8].institutions[0].ror | https://ror.org/0220mzb33 |
| authorships[8].institutions[0].type | education |
| authorships[8].institutions[0].lineage | https://openalex.org/I124357947, https://openalex.org/I183935753 |
| authorships[8].institutions[0].country_code | GB |
| authorships[8].institutions[0].display_name | King's College London |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Angela Cape |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | King's Clinical Trials Unit, Institute of Psychiatry, Psychology & Neuroscience,, King's College London, London, UK |
| authorships[9].author.id | https://openalex.org/A5030752596 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-0634-8548 |
| authorships[9].author.display_name | Haroon Ahmed |
| authorships[9].countries | GB |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I79510175 |
| authorships[9].affiliations[0].raw_affiliation_string | Cardiff University, Division of Population Medicine, Cardiff, UK |
| authorships[9].institutions[0].id | https://openalex.org/I79510175 |
| authorships[9].institutions[0].ror | https://ror.org/03kk7td41 |
| authorships[9].institutions[0].type | education |
| authorships[9].institutions[0].lineage | https://openalex.org/I79510175 |
| authorships[9].institutions[0].country_code | GB |
| authorships[9].institutions[0].display_name | Cardiff University |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Haroon Ahmed |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Cardiff University, Division of Population Medicine, Cardiff, UK |
| authorships[10].author.id | https://openalex.org/A5033129035 |
| authorships[10].author.orcid | https://orcid.org/0000-0003-2590-6565 |
| authorships[10].author.display_name | Christopher D. Ward |
| authorships[10].countries | GB |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I4210159183 |
| authorships[10].affiliations[0].raw_affiliation_string | NIHR Clinical Research Network South London, London, UK |
| authorships[10].institutions[0].id | https://openalex.org/I4210159183 |
| authorships[10].institutions[0].ror | https://ror.org/05fj7ar22 |
| authorships[10].institutions[0].type | government |
| authorships[10].institutions[0].lineage | https://openalex.org/I34931013, https://openalex.org/I4210159183 |
| authorships[10].institutions[0].country_code | GB |
| authorships[10].institutions[0].display_name | NIHR Clinical Research Network |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Christopher Ward |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | NIHR Clinical Research Network South London, London, UK |
| authorships[11].author.id | https://openalex.org/A5109652695 |
| authorships[11].author.orcid | |
| authorships[11].author.display_name | Peter Walsh |
| authorships[11].affiliations[0].raw_affiliation_string | British Liver Trust, Venta Court, Winchester, UK |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Peter Walsh |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | British Liver Trust, Venta Court, Winchester, UK |
| authorships[12].author.id | https://openalex.org/A5093572555 |
| authorships[12].author.orcid | |
| authorships[12].author.display_name | Kevin Besly |
| authorships[12].countries | GB |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I4210111135 |
| authorships[12].affiliations[0].raw_affiliation_string | Institute of Liver Studies, King's College Hospital NHS Foundation Trust, London, UK |
| authorships[12].institutions[0].id | https://openalex.org/I4210111135 |
| authorships[12].institutions[0].ror | https://ror.org/01n0k5m85 |
| authorships[12].institutions[0].type | healthcare |
| authorships[12].institutions[0].lineage | https://openalex.org/I4210111135 |
| authorships[12].institutions[0].country_code | GB |
| authorships[12].institutions[0].display_name | King's College Hospital NHS Foundation Trust |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Kevin Besly |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | Institute of Liver Studies, King's College Hospital NHS Foundation Trust, London, UK |
| authorships[13].author.id | https://openalex.org/A5056768920 |
| authorships[13].author.orcid | |
| authorships[13].author.display_name | Ane Zamalloa |
| authorships[13].countries | GB |
| authorships[13].affiliations[0].institution_ids | https://openalex.org/I4210111135 |
| authorships[13].affiliations[0].raw_affiliation_string | Institute of Liver Studies, King's College Hospital NHS Foundation Trust, London, UK |
| authorships[13].institutions[0].id | https://openalex.org/I4210111135 |
| authorships[13].institutions[0].ror | https://ror.org/01n0k5m85 |
| authorships[13].institutions[0].type | healthcare |
| authorships[13].institutions[0].lineage | https://openalex.org/I4210111135 |
| authorships[13].institutions[0].country_code | GB |
| authorships[13].institutions[0].display_name | King's College Hospital NHS Foundation Trust |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Ane Zamalloa |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | Institute of Liver Studies, King's College Hospital NHS Foundation Trust, London, UK |
| authorships[14].author.id | https://openalex.org/A5026390715 |
| authorships[14].author.orcid | https://orcid.org/0000-0002-4389-5284 |
| authorships[14].author.display_name | Joanna Kelly |
| authorships[14].countries | GB |
| authorships[14].affiliations[0].institution_ids | https://openalex.org/I183935753 |
| authorships[14].affiliations[0].raw_affiliation_string | King's Clinical Trials Unit, Institute of Psychiatry, Psychology & Neuroscience,, King's College London, London, UK |
| authorships[14].institutions[0].id | https://openalex.org/I183935753 |
| authorships[14].institutions[0].ror | https://ror.org/0220mzb33 |
| authorships[14].institutions[0].type | education |
| authorships[14].institutions[0].lineage | https://openalex.org/I124357947, https://openalex.org/I183935753 |
| authorships[14].institutions[0].country_code | GB |
| authorships[14].institutions[0].display_name | King's College London |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Joanna Kelly |
| authorships[14].is_corresponding | False |
| authorships[14].raw_affiliation_strings | King's Clinical Trials Unit, Institute of Psychiatry, Psychology & Neuroscience,, King's College London, London, UK |
| authorships[15].author.id | https://openalex.org/A5023799194 |
| authorships[15].author.orcid | |
| authorships[15].author.display_name | Ashis Mukhopadhya |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Ashis Mukhopadhya |
| authorships[15].is_corresponding | False |
| authorships[16].author.id | https://openalex.org/A5082393520 |
| authorships[16].author.orcid | |
| authorships[16].author.display_name | Alicija Vileito |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | Alicija Vileito |
| authorships[16].is_corresponding | False |
| authorships[17].author.id | https://openalex.org/A5061630115 |
| authorships[17].author.orcid | |
| authorships[17].author.display_name | Tracy Henderson |
| authorships[17].author_position | middle |
| authorships[17].raw_author_name | Tracy Henderson |
| authorships[17].is_corresponding | False |
| authorships[18].author.id | https://openalex.org/A5058205391 |
| authorships[18].author.orcid | https://orcid.org/0000-0002-0710-5644 |
| authorships[18].author.display_name | Gwilym J. Webb |
| authorships[18].author_position | middle |
| authorships[18].raw_author_name | Gwilym Webb |
| authorships[18].is_corresponding | False |
| authorships[19].author.id | https://openalex.org/A5110089166 |
| authorships[19].author.orcid | |
| authorships[19].author.display_name | Jerrian Joyce Andrada |
| authorships[19].author_position | middle |
| authorships[19].raw_author_name | Jerrian Joyce Andrada |
| authorships[19].is_corresponding | False |
| authorships[20].author.id | https://openalex.org/A5069840624 |
| authorships[20].author.orcid | https://orcid.org/0000-0001-8449-376X |
| authorships[20].author.display_name | Abigail Ford |
| authorships[20].author_position | middle |
| authorships[20].raw_author_name | Abigail Ford |
| authorships[20].is_corresponding | False |
| authorships[21].author.id | https://openalex.org/A5056583510 |
| authorships[21].author.orcid | https://orcid.org/0000-0002-1289-5492 |
| authorships[21].author.display_name | Cyril Sieberhagen |
| authorships[21].author_position | middle |
| authorships[21].raw_author_name | Cyril Sieberhagen |
| authorships[21].is_corresponding | False |
| authorships[22].author.id | https://openalex.org/A5065443937 |
| authorships[22].author.orcid | |
| authorships[22].author.display_name | Claire Burston |
| authorships[22].author_position | middle |
| authorships[22].raw_author_name | Claire Burston |
| authorships[22].is_corresponding | False |
| authorships[23].author.id | https://openalex.org/A5016527128 |
| authorships[23].author.orcid | |
| authorships[23].author.display_name | Carol Brooks |
| authorships[23].author_position | middle |
| authorships[23].raw_author_name | Carol Brooks |
| authorships[23].is_corresponding | False |
| authorships[24].author.id | https://openalex.org/A5016669132 |
| authorships[24].author.orcid | https://orcid.org/0000-0002-7000-9305 |
| authorships[24].author.display_name | Gavin Wright |
| authorships[24].author_position | middle |
| authorships[24].raw_author_name | Gavin Wright |
| authorships[24].is_corresponding | False |
| authorships[25].author.id | https://openalex.org/A5095706421 |
| authorships[25].author.orcid | |
| authorships[25].author.display_name | Bushena Miyesa |
| authorships[25].author_position | middle |
| authorships[25].raw_author_name | Bushena Miyesa |
| authorships[25].is_corresponding | False |
| authorships[26].author.id | https://openalex.org/A5086699118 |
| authorships[26].author.orcid | https://orcid.org/0000-0001-9402-4326 |
| authorships[26].author.display_name | Aimee Williams |
| authorships[26].author_position | middle |
| authorships[26].raw_author_name | Aimee Williams |
| authorships[26].is_corresponding | False |
| authorships[27].author.id | https://openalex.org/A5007189721 |
| authorships[27].author.orcid | https://orcid.org/0000-0002-8507-795X |
| authorships[27].author.display_name | Jay Patel |
| authorships[27].countries | GB |
| authorships[27].affiliations[0].institution_ids | https://openalex.org/I335284955, https://openalex.org/I4210152686 |
| authorships[27].affiliations[0].raw_affiliation_string | The Roger Williams Institute of Hepatology, Foundation for Liver Research, 111 Coldharbour Lane, London, SE5 9NT, UK |
| authorships[27].institutions[0].id | https://openalex.org/I335284955 |
| authorships[27].institutions[0].ror | https://ror.org/0143pk141 |
| authorships[27].institutions[0].type | nonprofit |
| authorships[27].institutions[0].lineage | https://openalex.org/I335284955 |
| authorships[27].institutions[0].country_code | GB |
| authorships[27].institutions[0].display_name | Foundation for Liver Research |
| authorships[27].institutions[1].id | https://openalex.org/I4210152686 |
| authorships[27].institutions[1].ror | https://ror.org/05jzxm583 |
| authorships[27].institutions[1].type | company |
| authorships[27].institutions[1].lineage | https://openalex.org/I4210152686 |
| authorships[27].institutions[1].country_code | GB |
| authorships[27].institutions[1].display_name | Williams (United Kingdom) |
| authorships[27].author_position | middle |
| authorships[27].raw_author_name | Jay Patel |
| authorships[27].is_corresponding | True |
| authorships[27].raw_affiliation_strings | The Roger Williams Institute of Hepatology, Foundation for Liver Research, 111 Coldharbour Lane, London, SE5 9NT, UK |
| authorships[28].author.id | https://openalex.org/A5032138828 |
| authorships[28].author.orcid | |
| authorships[28].author.display_name | Melchizedek Penacerrada |
| authorships[28].author_position | middle |
| authorships[28].raw_author_name | Melchizedek Penacerrada |
| authorships[28].is_corresponding | False |
| authorships[29].author.id | https://openalex.org/A5027061802 |
| authorships[29].author.orcid | https://orcid.org/0000-0001-7457-7396 |
| authorships[29].author.display_name | Gautham Appanna |
| authorships[29].author_position | middle |
| authorships[29].raw_author_name | Gautham Appanna |
| authorships[29].is_corresponding | False |
| authorships[30].author.id | https://openalex.org/A5108920363 |
| authorships[30].author.orcid | |
| authorships[30].author.display_name | Gifthy Perez |
| authorships[30].author_position | middle |
| authorships[30].raw_author_name | Gifthy Perez |
| authorships[30].is_corresponding | False |
| authorships[31].author.id | https://openalex.org/A5054100367 |
| authorships[31].author.orcid | https://orcid.org/0009-0007-9451-9020 |
| authorships[31].author.display_name | Joanne Elliott |
| authorships[31].author_position | middle |
| authorships[31].raw_author_name | Joanne Elliott |
| authorships[31].is_corresponding | False |
| authorships[32].author.id | https://openalex.org/A5027956565 |
| authorships[32].author.orcid | |
| authorships[32].author.display_name | Keval Naik |
| authorships[32].author_position | middle |
| authorships[32].raw_author_name | Keval Naik |
| authorships[32].is_corresponding | False |
| authorships[33].author.id | https://openalex.org/A5017392952 |
| authorships[33].author.orcid | |
| authorships[33].author.display_name | Susan Smolen |
| authorships[33].author_position | middle |
| authorships[33].raw_author_name | Susan Smolen |
| authorships[33].is_corresponding | False |
| authorships[34].author.id | https://openalex.org/A5109705625 |
| authorships[34].author.orcid | |
| authorships[34].author.display_name | Anna Beckwith |
| authorships[34].countries | GB |
| authorships[34].affiliations[0].institution_ids | https://openalex.org/I183935753 |
| authorships[34].affiliations[0].raw_affiliation_string | King's Clinical Trials Unit, Institute of Psychiatry, Psychology & Neuroscience,, King's College London, London, UK |
| authorships[34].institutions[0].id | https://openalex.org/I183935753 |
| authorships[34].institutions[0].ror | https://ror.org/0220mzb33 |
| authorships[34].institutions[0].type | education |
| authorships[34].institutions[0].lineage | https://openalex.org/I124357947, https://openalex.org/I183935753 |
| authorships[34].institutions[0].country_code | GB |
| authorships[34].institutions[0].display_name | King's College London |
| authorships[34].author_position | middle |
| authorships[34].raw_author_name | Anna Beckwith |
| authorships[34].is_corresponding | False |
| authorships[34].raw_affiliation_strings | King's Clinical Trials Unit, Institute of Psychiatry, Psychology & Neuroscience,, King's College London, London, UK |
| authorships[35].author.id | https://openalex.org/A5111174402 |
| authorships[35].author.orcid | |
| authorships[35].author.display_name | Matthew Foxton |
| authorships[35].author_position | middle |
| authorships[35].raw_author_name | Matthew Foxton |
| authorships[35].is_corresponding | False |
| authorships[36].author.id | https://openalex.org/A5090690196 |
| authorships[36].author.orcid | |
| authorships[36].author.display_name | Carina Bautista |
| authorships[36].author_position | middle |
| authorships[36].raw_author_name | Carina Bautista |
| authorships[36].is_corresponding | False |
| authorships[37].author.id | https://openalex.org/A5063224188 |
| authorships[37].author.orcid | https://orcid.org/0000-0002-1152-0568 |
| authorships[37].author.display_name | Matthew Cramp |
| authorships[37].author_position | middle |
| authorships[37].raw_author_name | Matthew Cramp |
| authorships[37].is_corresponding | False |
| authorships[38].author.id | https://openalex.org/A5093804249 |
| authorships[38].author.orcid | |
| authorships[38].author.display_name | Ada Laureen Nweze |
| authorships[38].author_position | middle |
| authorships[38].raw_author_name | Ada Laureen Nweze |
| authorships[38].is_corresponding | False |
| authorships[39].author.id | https://openalex.org/A5077581576 |
| authorships[39].author.orcid | |
| authorships[39].author.display_name | Gayatri Chakrabarty |
| authorships[39].author_position | middle |
| authorships[39].raw_author_name | Gayatri Chakrabarty |
| authorships[39].is_corresponding | False |
| authorships[40].author.id | https://openalex.org/A5075370219 |
| authorships[40].author.orcid | |
| authorships[40].author.display_name | Indhuja Rajkumar |
| authorships[40].author_position | middle |
| authorships[40].raw_author_name | Indhuja Rajkumar |
| authorships[40].is_corresponding | False |
| authorships[41].author.id | https://openalex.org/A5112375556 |
| authorships[41].author.orcid | |
| authorships[41].author.display_name | Merlin James |
| authorships[41].countries | GB |
| authorships[41].affiliations[0].institution_ids | https://openalex.org/I183935753 |
| authorships[41].affiliations[0].raw_affiliation_string | Health Service and Population Research Department, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK |
| authorships[41].institutions[0].id | https://openalex.org/I183935753 |
| authorships[41].institutions[0].ror | https://ror.org/0220mzb33 |
| authorships[41].institutions[0].type | education |
| authorships[41].institutions[0].lineage | https://openalex.org/I124357947, https://openalex.org/I183935753 |
| authorships[41].institutions[0].country_code | GB |
| authorships[41].institutions[0].display_name | King's College London |
| authorships[41].author_position | middle |
| authorships[41].raw_author_name | Merlin James |
| authorships[41].is_corresponding | False |
| authorships[41].raw_affiliation_strings | Health Service and Population Research Department, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK |
| authorships[42].author.id | https://openalex.org/A5046286666 |
| authorships[42].author.orcid | https://orcid.org/0000-0003-1041-9844 |
| authorships[42].author.display_name | Steven Masson |
| authorships[42].author_position | middle |
| authorships[42].raw_author_name | Steven Masson |
| authorships[42].is_corresponding | False |
| authorships[43].author.id | https://openalex.org/A5111174403 |
| authorships[43].author.orcid | |
| authorships[43].author.display_name | Sheenu Thomas |
| authorships[43].author_position | middle |
| authorships[43].raw_author_name | Sheenu Thomas |
| authorships[43].is_corresponding | False |
| authorships[44].author.id | https://openalex.org/A5088010611 |
| authorships[44].author.orcid | |
| authorships[44].author.display_name | Lucy Dixon |
| authorships[44].author_position | middle |
| authorships[44].raw_author_name | Lucy Dixon |
| authorships[44].is_corresponding | False |
| authorships[45].author.id | https://openalex.org/A5013006695 |
| authorships[45].author.orcid | https://orcid.org/0000-0002-3642-5604 |
| authorships[45].author.display_name | S. Hogg |
| authorships[45].author_position | middle |
| authorships[45].raw_author_name | Sarah Hogg |
| authorships[45].is_corresponding | False |
| authorships[46].author.id | https://openalex.org/A5055294815 |
| authorships[46].author.orcid | |
| authorships[46].author.display_name | Louise Finlay |
| authorships[46].author_position | middle |
| authorships[46].raw_author_name | Louise Finlay |
| authorships[46].is_corresponding | False |
| authorships[47].author.id | https://openalex.org/A5038009766 |
| authorships[47].author.orcid | |
| authorships[47].author.display_name | Kuldeep Cheent |
| authorships[47].author_position | middle |
| authorships[47].raw_author_name | Kuldeep Cheent |
| authorships[47].is_corresponding | False |
| authorships[48].author.id | https://openalex.org/A5041220036 |
| authorships[48].author.orcid | https://orcid.org/0000-0002-8161-6645 |
| authorships[48].author.display_name | Jessica K. Camp |
| authorships[48].author_position | middle |
| authorships[48].raw_author_name | Jessica Camp |
| authorships[48].is_corresponding | False |
| authorships[49].author.id | https://openalex.org/A5066899261 |
| authorships[49].author.orcid | https://orcid.org/0000-0002-9761-9795 |
| authorships[49].author.display_name | Adrian J. Stanley |
| authorships[49].author_position | middle |
| authorships[49].raw_author_name | Adrian Stanley |
| authorships[49].is_corresponding | False |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://trialsjournal.biomedcentral.com/counter/pdf/10.1186/s13063-024-08063-3 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Beta-blockers or Placebo for Primary Prophylaxis (BOPPP) of oesophageal varices: study protocol for a randomised controlled trial |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-23T05:10:03.516525 |
| primary_topic.id | https://openalex.org/T10337 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 1.0 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2721 |
| primary_topic.subfield.display_name | Hepatology |
| primary_topic.display_name | Liver Disease and Transplantation |
| related_works | https://openalex.org/W2336270053, https://openalex.org/W2809712542, https://openalex.org/W2063134252, https://openalex.org/W4380576252, https://openalex.org/W2320450612, https://openalex.org/W2375699071, https://openalex.org/W3216438752, https://openalex.org/W1228830179, https://openalex.org/W2792340342, https://openalex.org/W3080946622 |
| cited_by_count | 5 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 3 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 2 |
| locations_count | 6 |
| best_oa_location.id | doi:10.1186/s13063-024-08063-3 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S109512841 |
| best_oa_location.source.issn | 1745-6215 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 1745-6215 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Trials |
| best_oa_location.source.host_organization | https://openalex.org/P4310319900 |
| best_oa_location.source.host_organization_name | Springer Science+Business Media |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310319900, https://openalex.org/P4310319965 |
| best_oa_location.source.host_organization_lineage_names | Springer Science+Business Media, Springer Nature |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://trialsjournal.biomedcentral.com/counter/pdf/10.1186/s13063-024-08063-3 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Trials |
| best_oa_location.landing_page_url | https://doi.org/10.1186/s13063-024-08063-3 |
| primary_location.id | doi:10.1186/s13063-024-08063-3 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S109512841 |
| primary_location.source.issn | 1745-6215 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 1745-6215 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Trials |
| primary_location.source.host_organization | https://openalex.org/P4310319900 |
| primary_location.source.host_organization_name | Springer Science+Business Media |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310319900, https://openalex.org/P4310319965 |
| primary_location.source.host_organization_lineage_names | Springer Science+Business Media, Springer Nature |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://trialsjournal.biomedcentral.com/counter/pdf/10.1186/s13063-024-08063-3 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Trials |
| primary_location.landing_page_url | https://doi.org/10.1186/s13063-024-08063-3 |
| publication_date | 2024-04-16 |
| publication_year | 2024 |
| referenced_works | https://openalex.org/W2133275424, https://openalex.org/W2930092408, https://openalex.org/W1964051982, https://openalex.org/W2078378195, https://openalex.org/W3002822153, https://openalex.org/W2995510644, https://openalex.org/W4294989928, https://openalex.org/W2163875620, https://openalex.org/W4281625022, https://openalex.org/W4313398873, https://openalex.org/W3083453401, https://openalex.org/W4200473175, https://openalex.org/W2922822790, https://openalex.org/W2118657129, https://openalex.org/W4210764933, https://openalex.org/W4306632340, https://openalex.org/W2343426002, https://openalex.org/W4310461966, https://openalex.org/W2028532700, https://openalex.org/W1979290264, https://openalex.org/W2674995983, https://openalex.org/W3093223973 |
| referenced_works_count | 22 |
| abstract_inverted_index.( | 408 |
| abstract_inverted_index.) | 410 |
| abstract_inverted_index.1 | 238 |
| abstract_inverted_index.5 | 244 |
| abstract_inverted_index.a | 71, 100, 157, 169, 206, 333, 393 |
| abstract_inverted_index.(a | 166 |
| abstract_inverted_index.18 | 118 |
| abstract_inverted_index.24 | 433 |
| abstract_inverted_index.36 | 177 |
| abstract_inverted_index.55 | 147 |
| abstract_inverted_index.It | 66, 204 |
| abstract_inverted_index.VH | 89 |
| abstract_inverted_index.an | 78, 232, 318 |
| abstract_inverted_index.at | 77, 317 |
| abstract_inverted_index.be | 133, 388, 399 |
| abstract_inverted_index.by | 17, 237, 243, 369 |
| abstract_inverted_index.in | 13, 109, 149, 189, 234, 288, 315, 358, 392, 413 |
| abstract_inverted_index.is | 4, 36, 43, 99, 197, 205, 309, 327 |
| abstract_inverted_index.mg | 165 |
| abstract_inverted_index.of | 10, 19, 40, 48, 187, 212, 260, 268, 286, 321, 343, 355, 384, 401 |
| abstract_inverted_index.on | 156, 312, 431 |
| abstract_inverted_index.or | 120, 168, 173, 191, 217, 221, 240, 255, 263, 304 |
| abstract_inverted_index.to | 22, 27, 62, 136, 142, 160, 179, 183, 200, 253, 280, 296, 351 |
| abstract_inverted_index.up | 211 |
| abstract_inverted_index.we | 336 |
| abstract_inverted_index.1:1 | 158 |
| abstract_inverted_index.740 | 144 |
| abstract_inverted_index.The | 96, 139, 194, 276, 364, 382 |
| abstract_inverted_index.UK. | 151 |
| abstract_inverted_index.and | 42, 54, 64, 90, 113, 124, 246, 272, 284, 292, 341, 362, 411 |
| abstract_inverted_index.are | 32, 85, 153 |
| abstract_inverted_index.can | 87, 302 |
| abstract_inverted_index.for | 176, 390 |
| abstract_inverted_index.has | 366 |
| abstract_inverted_index.new | 216, 220 |
| abstract_inverted_index.the | 6, 37, 46, 150, 185, 198, 282, 330, 339, 353, 356, 370, 385, 402, 405, 414 |
| abstract_inverted_index.top | 7 |
| abstract_inverted_index.use | 342 |
| abstract_inverted_index.via | 404 |
| abstract_inverted_index.(VH, | 215 |
| abstract_inverted_index.6.25 | 164 |
| abstract_inverted_index.ACD. | 193 |
| abstract_inverted_index.MELD | 241 |
| abstract_inverted_index.NSBB | 325 |
| abstract_inverted_index.aged | 117 |
| abstract_inverted_index.aims | 141, 279 |
| abstract_inverted_index.been | 367 |
| abstract_inverted_index.bled | 131 |
| abstract_inverted_index.five | 8 |
| abstract_inverted_index.have | 129 |
| abstract_inverted_index.i.e. | 81 |
| abstract_inverted_index.made | 210 |
| abstract_inverted_index.once | 172 |
| abstract_inverted_index.that | 128, 338 |
| abstract_inverted_index.this | 299 |
| abstract_inverted_index.time | 199 |
| abstract_inverted_index.when | 82 |
| abstract_inverted_index.will | 132, 345, 387, 398 |
| abstract_inverted_index.with | 45, 122, 290, 324, 348 |
| abstract_inverted_index.(BLT) | 418 |
| abstract_inverted_index.(HE), | 225 |
| abstract_inverted_index.(NHS) | 374 |
| abstract_inverted_index.(RCT) | 108 |
| abstract_inverted_index.(REC) | 378 |
| abstract_inverted_index.2019. | 434 |
| abstract_inverted_index.April | 432 |
| abstract_inverted_index.BOPPP | 97, 277, 406 |
| abstract_inverted_index.Liver | 2, 416 |
| abstract_inverted_index.NSBB) | 167 |
| abstract_inverted_index.There | 308 |
| abstract_inverted_index.Trial | 420 |
| abstract_inverted_index.Trust | 417 |
| abstract_inverted_index.Wales | 112 |
| abstract_inverted_index.areas | 31 |
| abstract_inverted_index.care. | 360 |
| abstract_inverted_index.costs | 271 |
| abstract_inverted_index.death | 12 |
| abstract_inverted_index.enrol | 143 |
| abstract_inverted_index.first | 201 |
| abstract_inverted_index.grade | 236, 239 |
| abstract_inverted_index.large | 256 |
| abstract_inverted_index.leads | 61 |
| abstract_inverted_index.life, | 269 |
| abstract_inverted_index.never | 130 |
| abstract_inverted_index.older | 121 |
| abstract_inverted_index.other | 28 |
| abstract_inverted_index.power | 182 |
| abstract_inverted_index.ratio | 159 |
| abstract_inverted_index.rise, | 23 |
| abstract_inverted_index.score | 242 |
| abstract_inverted_index.small | 125, 293 |
| abstract_inverted_index.stage | 320 |
| abstract_inverted_index.trial | 98, 107, 140, 278, 331, 365, 386 |
| abstract_inverted_index.twice | 174 |
| abstract_inverted_index.which | 60 |
| abstract_inverted_index.years | 119 |
| abstract_inverted_index.yield | 332 |
| abstract_inverted_index.(ACD). | 94 |
| abstract_inverted_index.(SBP), | 229 |
| abstract_inverted_index.Deaths | 15 |
| abstract_inverted_index.Ethics | 361, 376 |
| abstract_inverted_index.Health | 372 |
| abstract_inverted_index.ISRCTN | 426 |
| abstract_inverted_index.Portal | 34 |
| abstract_inverted_index.Should | 329 |
| abstract_inverted_index.across | 146 |
| abstract_inverted_index.attain | 180 |
| abstract_inverted_index.become | 346 |
| abstract_inverted_index.caused | 16 |
| abstract_inverted_index.causes | 9 |
| abstract_inverted_index.daily, | 175 |
| abstract_inverted_index.deaths | 25 |
| abstract_inverted_index.either | 162 |
| abstract_inverted_index.event. | 203 |
| abstract_inverted_index.medium | 254 |
| abstract_inverted_index.portal | 322 |
| abstract_inverted_index.reduce | 91, 305 |
| abstract_inverted_index.small, | 86 |
| abstract_inverted_index.stage, | 80 |
| abstract_inverted_index.termed | 57 |
| abstract_inverted_index.whilst | 24 |
| abstract_inverted_index.within | 5 |
| abstract_inverted_index.(NSBB), | 74 |
| abstract_inverted_index.British | 415 |
| abstract_inverted_index.EUDRACT | 422 |
| abstract_inverted_index.Service | 373 |
| abstract_inverted_index.adults. | 14 |
| abstract_inverted_index.disease | 3, 30 |
| abstract_inverted_index.earlier | 79, 319 |
| abstract_inverted_index.ectopic | 264 |
| abstract_inverted_index.hepatic | 52, 58, 223, 306 |
| abstract_inverted_index.include | 251 |
| abstract_inverted_index.matched | 170 |
| abstract_inverted_index.months, | 178 |
| abstract_inverted_index.number: | 380, 424, 428 |
| abstract_inverted_index.outcome | 196, 209 |
| abstract_inverted_index.points, | 245 |
| abstract_inverted_index.prevent | 88, 303 |
| abstract_inverted_index.primary | 38, 195, 208, 359 |
| abstract_inverted_index.quality | 267 |
| abstract_inverted_index.receive | 161 |
| abstract_inverted_index.related | 26 |
| abstract_inverted_index.remains | 67 |
| abstract_inverted_index.result, | 335 |
| abstract_inverted_index.results | 383, 403 |
| abstract_inverted_index.subject | 135 |
| abstract_inverted_index.therapy | 326 |
| abstract_inverted_index.varices | 84, 127, 295 |
| abstract_inverted_index.website | 407 |
| abstract_inverted_index.whether | 69, 298, 313 |
| abstract_inverted_index.Abstract | 0 |
| abstract_inverted_index.England, | 110 |
| abstract_inverted_index.Ireland. | 115 |
| abstract_inverted_index.National | 371 |
| abstract_inverted_index.Northern | 114 |
| abstract_inverted_index.Patients | 116, 152 |
| abstract_inverted_index.Research | 375 |
| abstract_inverted_index.adequate | 181 |
| abstract_inverted_index.approved | 368 |
| abstract_inverted_index.ascites, | 51, 219 |
| abstract_inverted_index.clinical | 283, 310 |
| abstract_inverted_index.continue | 21 |
| abstract_inverted_index.gastric, | 261 |
| abstract_inverted_index.increase | 233 |
| abstract_inverted_index.informed | 400 |
| abstract_inverted_index.journal. | 396 |
| abstract_inverted_index.outcomes | 250 |
| abstract_inverted_index.partners | 412 |
| abstract_inverted_index.pathways | 349 |
| abstract_inverted_index.patients | 145, 289 |
| abstract_inverted_index.placebo, | 171 |
| abstract_inverted_index.positive | 334 |
| abstract_inverted_index.randomly | 155 |
| abstract_inverted_index.reducing | 192 |
| abstract_inverted_index.sequelae | 39 |
| abstract_inverted_index.variceal | 49, 213 |
| abstract_inverted_index.varices, | 258, 265 |
| abstract_inverted_index.Committee | 377 |
| abstract_inverted_index.Scotland, | 111 |
| abstract_inverted_index.Secondary | 249 |
| abstract_inverted_index.all-cause | 92 |
| abstract_inverted_index.allocated | 154 |
| abstract_inverted_index.bacterial | 227 |
| abstract_inverted_index.cirrhosis | 20, 41, 123, 291 |
| abstract_inverted_index.composite | 207 |
| abstract_inverted_index.criteria. | 138 |
| abstract_inverted_index.determine | 184, 297 |
| abstract_inverted_index.developed | 350 |
| abstract_inverted_index.duodenal, | 262 |
| abstract_inverted_index.equipoise | 311 |
| abstract_inverted_index.exclusion | 137 |
| abstract_inverted_index.hospitals | 148 |
| abstract_inverted_index.non-liver | 29 |
| abstract_inverted_index.premature | 11 |
| abstract_inverted_index.reference | 423, 427 |
| abstract_inverted_index.submitted | 389 |
| abstract_inverted_index.survival. | 274 |
| abstract_inverted_index.syndrome, | 231 |
| abstract_inverted_index.uncertain | 68 |
| abstract_inverted_index.worsening | 218, 222 |
| abstract_inverted_index.(reference | 379 |
| abstract_inverted_index.Background | 1 |
| abstract_inverted_index.Discussion | 275 |
| abstract_inverted_index.Registered | 430 |
| abstract_inverted_index.anticipate | 337 |
| abstract_inverted_index.associated | 44 |
| abstract_inverted_index.carvedilol | 163, 188, 287, 344 |
| abstract_inverted_index.cirrhosis, | 316 |
| abstract_inverted_index.controlled | 106 |
| abstract_inverted_index.declining. | 33 |
| abstract_inverted_index.healthcare | 270 |
| abstract_inverted_index.infection, | 55 |
| abstract_inverted_index.medication | 357 |
| abstract_inverted_index.mortality. | 65, 248 |
| abstract_inverted_index.pragmatic, | 101 |
| abstract_inverted_index.preventing | 190 |
| abstract_inverted_index.randomised | 105 |
| abstract_inverted_index.recruited, | 134 |
| abstract_inverted_index.scientific | 395 |
| abstract_inverted_index.widespread | 347 |
| abstract_inverted_index.beneficial. | 328 |
| abstract_inverted_index.carvedilol, | 76 |
| abstract_inverted_index.development | 47, 259 |
| abstract_inverted_index.haemorrhage | 214 |
| abstract_inverted_index.hepatorenal | 230 |
| abstract_inverted_index.intervening | 314 |
| abstract_inverted_index.investigate | 281 |
| abstract_inverted_index.oesophageal | 83, 126, 257, 294 |
| abstract_inverted_index.participant | 266 |
| abstract_inverted_index.peritonitis | 228 |
| abstract_inverted_index.progression | 252 |
| abstract_inverted_index.publication | 391 |
| abstract_inverted_index.spontaneous | 226 |
| abstract_inverted_index.standardise | 352 |
| abstract_inverted_index.19/YH/0015). | 381 |
| abstract_inverted_index.Child–Pugh | 235 |
| abstract_inverted_index.Participants | 397 |
| abstract_inverted_index.beta-blocker | 73, 301 |
| abstract_inverted_index.collectively | 56 |
| abstract_inverted_index.haemorrhage, | 50 |
| abstract_inverted_index.hypertension | 35 |
| abstract_inverted_index.multicentre, | 102 |
| abstract_inverted_index.registration | 421 |
| abstract_inverted_index.specifically | 75 |
| abstract_inverted_index.administering | 70 |
| abstract_inverted_index.complications | 18 |
| abstract_inverted_index.dissemination | 363 |
| abstract_inverted_index.effectiveness | 186 |
| abstract_inverted_index.hypertension, | 323 |
| abstract_inverted_index.liver-related | 247 |
| abstract_inverted_index.non-selective | 72, 300 |
| abstract_inverted_index.organisation. | 419 |
| abstract_inverted_index.peer-reviewed | 394 |
| abstract_inverted_index.Methods/design | 95 |
| abstract_inverted_index.administration | 340, 354 |
| abstract_inverted_index.decompensating | 202 |
| abstract_inverted_index.decompensation | 93 |
| abstract_inverted_index.encephalopathy | 53, 224 |
| abstract_inverted_index.ISRCTN10324656. | 429 |
| abstract_inverted_index.decompensation, | 59 |
| abstract_inverted_index.decompensation. | 307 |
| abstract_inverted_index.hospitalisation | 63 |
| abstract_inverted_index.transplant-free | 273 |
| abstract_inverted_index.triple-blinded, | 104 |
| abstract_inverted_index.2018–002509-78. | 425 |
| abstract_inverted_index.cost-effectiveness | 285 |
| abstract_inverted_index.placebo-controlled, | 103 |
| abstract_inverted_index.www.boppp-trial.org | 409 |
| cited_by_percentile_year.max | 97 |
| cited_by_percentile_year.min | 94 |
| corresponding_author_ids | https://openalex.org/A5080274937, https://openalex.org/A5007189721 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 176 |
| corresponding_institution_ids | https://openalex.org/I335284955, https://openalex.org/I4210111135, https://openalex.org/I4210152686 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8199999928474426 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.88716814 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |